Clinical trial
Safety and Efficacy of Apixaban in Severe Renal Impairment
NCT03399305 is registered in ClinicalTrials.gov with Albert Einstein College of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy of Apixaban in Severe Renal Impairment
- Lead sponsor
- Albert Einstein College of Medicine
- Phase
- Observational
- Overall status
- Withdrawn
- Start date
- May 10, 2017
- Completion date
- August 24, 2022
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
anticoagulant-induced bleeding, renal disease, end stage